






   
<rss version="2.0">
  <channel>
    <title>JOURNAL OF RADIATION ONCOLOGY AND PALLIATION, Year 2018 Issue 2</title>
    <link>https://radiation-palliative.com/?mod=sayi_detay&amp;sayi_id=2802</link>
    <description>JOURNAL OF RADIATION ONCOLOGY AND PALLIATION</description>
    <language>en</language>
    <pubDate>2024-08-29</pubDate>
    <generator/>
    <item>
      <title>Demonstration of radiation dose effect on thyroid with dental CBCT</title>
      <link>https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73417</link>
      <guid isPermaLink="true">https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73417</guid>
      <author>Ali Hikmet ErişHuriye Şenay Kızıltan ,Özgür Kablan , Ertuğrul Tekçe ,Pelin Altınok Süt ,Kemal Berk , Tuba Ünver ,Alpaslan Mayadağlı ,Teoman Aydın , Ceren Şimşek ,Direnç Özlem Aksoy </author>
      <description>BACKGROUND: Radiation is taken at differentrates according to the devices used fordiagnostic purposes. Cone Beam ComputedTomography (CBCT) in dentistry will result in aradiation dose effect due to CBCT in patientswho have received Cone Beam ComputedTomography (CBCT). This dose from CBCTshould be taken into account when calculatingdosimetric study with the aim of not exceedingthe maximum dose that can be taken annually.we started a study in our clinic.METHOD: The tooth CBCT device was used inthis study. Directly and indrectally, four times ofdosimetric measurements were taken with a 0.6cc silyldrinic ion chamber placed in a largePTW plexiglass transparent cap. According tothe results obtained from these measurements,approximately average dose obtained with directmeasurements was determined as 4,789 mGyand indirect dose as 450 µSv.CONCLUSION: The indirect dose is 450 µSvand this dose is normally 5 times higher thanthat normally required for the thyroid.</description>
      <pubDate>2024-08-29</pubDate>
    </item>
    <item>
      <title>A multidisciplinary approach to palliative care for	a terminal gastric cancer	 patient</title>
      <link>https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73418</link>
      <guid isPermaLink="true">https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73418</guid>
      <author>Medina İsmaylovaAyşe Güneş Bayır ,Meryem Başıbüyü ,Ceyda Demirtaş ,Kürşad Gül ,Ali Hikmet Eriş ,Teoman Aydın ,Alpaslan Mayadağlı ,Çiğdem Kınık , Muharrem Şimşek ,Adem Akçakaya </author>
      <description>BACKGROUND: When the general situation ofthe patients becomes worse, the patient'sfamilies and the patient can not cope with thisproblem and apply to the hospital. Integratedpalliative care (IPC) has been introduced moreappropriate to patients and family carers needs.It aims to achieve quality of life for the patientand the family.CASE REPORT: The patient was diagnosedwith gastric cancer which stage was T4N3M1.Oral capecitabine treatment started. Afterrecurrence of gastroesophageal area, palliativeradiotherapy and concurrent oral capecitabinetreatment were used. After 2 months, tumorimplants were detected in the abdominal wall.The patient's pain had palliatied after 40Gy RT.After 6 months the tumor marker values began torise and the patient was treated with cisplatin for2 cure but grade 3 neurotoxicity occured. Thepatient was admitted to our palliative caredepartment with oral malnutrition and deliriumfindings. The Patient nutrition screening toolswere shown to be malnutrition. In thepsychological evaluation, it was determined thathe was in the process of accepting the disease byleaving the stages of shock, anger and denialbehind in the process between diagnosis andpalliative care unit.Significant improvement was seen in deliriumfindings after corticosteroids.The patient was instructed to use his musclestwice a day, exercised, and mobilized.Highcalorie nutrition support was provided to thepatient as enteral nutrition product incooperation with the physician.Cognitive Existentialist psychotherapy wasapplied to the patient twice a week. Acceptanceof the socioeconomic and physical limitations brought about by the disease, future plan,treatment compliance studies.RESULTS: Patient was discharged by oralfeeding, VAS value 2, ECOG Performance score3, improved delirium table after two months.Palliative care units were also presented as acase study showing how important themultidisciplinary approach is for patients in thissituation.DISCUSSIONS: It may be possible to deal withsome serious problems with a good evaluationand team work in terminal period illnesses.There are many scales developed to evaluate thesituation of patients and their families. Thesecan be identified with the appropriate ones</description>
      <pubDate>2024-08-29</pubDate>
    </item>
    <item>
      <title>Palliative Bioresonance Therapy for metastatic cancer patients</title>
      <link>https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73419</link>
      <guid isPermaLink="true">https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73419</guid>
      <author>Esra KırseverHuriye Şenay Kızıltan ,Rabiye Yılmaz ,Ayşe Güneş Bayır ,Meryem Başıbüyük  ,Ali Hikmet Eriş ,Fatma Betül Çakır ,Kürşat Gül , Muharrem Şimşek ,Ayşe Kızıltepe ,Aslı Gümüş </author>
      <description>BACKGROUND: Patients with metastatic cancerwho experience chemotherapy and radiotherapygive a good response at the beginning but theirlife usually very distressed and short due to theexcess of side effects. In these patients, treatmentsthat have high side effects should be either neverapplied or should be treated with side effects. Weperformed a study in our clinic with bioresonance(BRT) therapy aimed at reducing side effects orcomplaints in patients with metastatic cancer.METHODS: Patients undergoing BRT treatmentwere assessed for pre- and post-BRTperformance, pain scores, clinical and laboratoryresponse findings. A prospective study was conducted on 37 patients with metastatic cancer.Using the local electrodes of the BICOM machine,band and frequency programs suitable forcomplaints such as pain, dyspnea, nausea,thrombophlebitis, paresis and plegeus, asciteswere selected and treated.RESULTS: There was a strong and significantcorrelation between the number of responses andsessions received with BRT (r = 0.6 p &lt;0.01).There was a significant difference betweentreatment response averages of BRT treatmentgroups according to ECOG score.DISCUSSION: Significant symptomaticimprovement and palliation were observed withBRT in stage IV patients.CONCLUSION: The BRT method is a reliableand effective treatment modality that increases thesuccess of conventional treatment and reducesside effects and contributes to the quality of lifeand palliation of patients</description>
      <pubDate>2024-08-29</pubDate>
    </item>
    <item>
      <title>Renal Cell Carcinoma and Metastatic Sites</title>
      <link>https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73420</link>
      <guid isPermaLink="true">https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73420</guid>
      <author>Ganime ÇobanAltay Aliyev ,Pelin Yıldız ,Nurcan Ünver ,Nurhan Şahin </author>
      <description>BACKGROUND: Renal cell carcinomaaccounts for about 3% of adult cancers. Themost common type is a 70% clear cellcarcinoma. Approximately 30% of patients havedeveloped metastasis at the time of diagnosis,and metastasis develops following nephrectomyin one third.METHODS: The study included the cases thatwere diagnosed by operation for primary ormetastasis between 2014 and 2016, and thathave been followed up by the Bezmialem VakifUniversity, Department of Medical Oncology.The sites of metastasis for metastatic RCCs andhow long after the time of diagnosis metastasisdeveloped were recorded. The demographic dataand metastatic sites of the cases are listed.RESULTS: The most common metastatic sitesare the lung. However, the rare settlementsreported in the literature are noteworthy.</description>
      <pubDate>2024-08-29</pubDate>
    </item>
    <item>
      <title>Coconut oil may be a palliative therapy agent against radiotherapy or chemotherapy related neurotoxicity and Alzheimer</title>
      <link>https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73421</link>
      <guid isPermaLink="true">https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73421</guid>
      <author>Medina IsmaylovaPelin Altınok Süt  ,Alpaslan Mayadağlı </author>
      <description/>
      <pubDate>2024-08-29</pubDate>
    </item>
    <item>
      <title>Quality control methods and analyzes of the tomotherapy</title>
      <link>https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73422</link>
      <guid isPermaLink="true">https://radiation-palliative.com/?mod=makale_tr_ozet&amp;makale_id=73422</guid>
      <author>Özgür KablanAli Hikmet Eriş </author>
      <description/>
      <pubDate>2024-08-29</pubDate>
    </item>
  </channel>
</rss>


